InvestorsHub Logo
Followers 91
Posts 1154
Boards Moderated 0
Alias Born 07/20/2011

Re: Trompete post# 9026

Tuesday, 10/15/2019 3:17:51 AM

Tuesday, October 15, 2019 3:17:51 AM

Post# of 19459

Nothing wrong with being short Trompete, but hopefully it was somewhere north $0.01. A decent PR and a little short squeeze this would be epic.

You are probably right about an O/S increase with the share volume.

However... Its not the full 600 mil and even if it was that's still a relatively small A/S.

As far as your bankruptcy claims... they straight up say that they can get government funding/are government funded it just slows everything down.

Emory university owns 10%, and they have exclusive rights to vaccine technology with them. The roster has 2 of the top 25 people in vaccines. While you might not like Dodd he graduated from Harvard with an MBA, and has been in the industry for 40 years. They also want to up-list and he has already run a Nasdaq company.

Look at the reporting, consistent updates, and transparency... there is obviously a bigger play they are working on.

Feel free to show some credentials that makes you qualified to tell us why a bunch of PHD's, a university, a Harvard MBA with 40 years of experience in the field and ran a Nasdaq listed company are wrong.

Either way, I'll let you get back to your agenda of trying to scare people off.

Cheers!


Why go anywhere else? Learn - Follow - Profit
MMStockplay's Money Makers

http://www.investorshub.advfn.com/MMStockPlays-Money-Makers-25119/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News